INCYTE GENOMICS SIGNS AGREEMENT WITH ACCELRYS.Accelrys Inc., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Pharmacopeia pharmacopeia /phar·ma·co·pe·ia/ (-ko-pe´ah) an authoritative treatise on drugs and their preparations. See also USP. pharmacopei´al United States Pharmacopeia see under U. , Inc., (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : PCOP PCOP Plasma Colloid Osmotic Pressure PCOP Phurst Church of Phun (audience participation humor experience) PCOP Palliative Care Outreach Program (Ottawa, Ontario, Canada) ), has signed an agreement with Incyte Genomics, Inc. (NASDAQ:INCY) to provide the functional annotations for 10,000 protein sequences based on Incyte's proprietary collection of rarely expressed human genes. Financial terms were not disclosed. The agreement calls for Accelrys to functionally annotate annotate - annotation these sequences with GeneAtlas(TM), the company's application for high throughput sequence and structure-based annotation 1. (programming, compiler) annotation - Extra information associated with a particular point in a document or program. Annotations may be added either by a compiler or by the programmer. . The results of the annotation will be delivered to Incyte in AtlasStore(TM), Accelrys' Oracle-based relational database relational database Database in which all data are represented in tabular form. The description of a particular entity is provided by the set of its attribute values, stored as one row or record of the table, called a tuple. for storing protein 3D annotations, as well as sequence, structural, chemical and functional information. In addition, Accelrys will provide Incyte with Discovery Studio(TM) data mining applications in order to access Atlas Store and view protein 3D annotations and structural models. By utilizing Discovery Studio compliant applications to view the structures, Incyte will become one of the first genetic research firms to access Accelrys' developing enterprise-wide solution for supporting integrated pharmaceutical disco very. "We're very excited about this agreement and look forward to developing a long-standing relationship with Incyte - a pioneer and leader in genomic research," said Scott Kahn, Ph.D., general manager and senior vice president, Accelrys Life Science. "Based on our previous success using this proprietary technology to annotate 89% of the publicly available human genome The human genome is the genome of Homo sapiens, which is composed of 24 distinct pairs of chromosomes (22 autosomal + X + Y) with a total of approximately 3 billion DNA base pairs containing an estimated 20,000–25,000 genes. , we expect that the information from these newly annotated proteins will facilitate Incyte's new therapeutic discovery and development initiative." "Incyte has an appreciable number of proprietary gene sequences for which little is known about the possible functions of their encoded protein," said Robert Stein, M.D, Ph.D., president and chief scientific officer of Incyte . "Accelrys' high throughput technologies for predicting protein structure and recognizing similarities to other proteins of known function should be very useful in gaining a functional perspective on many of Incyte's proprietary gene sequences. Ultimately, this should help us identify pharmaceutical opportunities for our therapeutic discovery and development initiatives and to advance our gene-related intellectual property portfolio and information offerings." About Incyte Genomics Incyte Genomics, Inc. has the largest commercial portfolio of issued United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. patents covering human, full-length genes and the proteins they encode and is leveraging its leading intellectual property and genomic information position to be a leader in therapeutic small molecule, secreted protein and antibody discoveries. In addition, Incyte has also developed the leading integrated platform of genomic technologies designed to aid in the understanding of the molecular basis of disease. Incyte develops and markets genomic databases and licenses pharmaceutically relevant intellectual property. These offerings facilitate pharmaceutical and biotechnology researchers in their drug discovery and development; including gene discovery, understanding disease pathways, identifying new disease targets and the discovery and correlation of gene sequence variation to disease. For more information, visit http://www.incyte.com. About Accelrys Accelrys is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists, and materials scientists for product design, drug discovery, and development. Accelrys' platform technology and consulting services enable enterprise -wide solutions tailored to today's leading research organizations. The company's three main centers of excellence are in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , CA, Princeton, N J, and Cambridge, UK. These centers combine research and product development with facilities to support significant collaborative projects. Accelrys is a subsidiary of Pharmacopeia, Inc. (NASDAQ:PCOP) and was launched in Jun e 2001, combining leading software companies Molecular Simulations Inc., Synopsys Scientific Systems, Oxford Molecular, GCG GCG Genetics Computer Group GCG Glucagon GCG Good Corporate Governance GCG Global Consumer Group GCG Global Church of God GCG Generalized Conjugate Gradient GCG Global Change Game GCG Geological Curators' Group GCG Giant-Cell Granuloma , and Synomics Ltd. For more information, visit http://www.accelrys.com or call (858)799-5393. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion